Today (10/19), the U.S. Food and Drug Administration (FDA) approved Eurofins U.S Clinical Diagnostics at-home COVID-19 test which provides test result within 24 hours and is minimally invasive. This is the first FDA approved self-administered test in circulation from Eurofins, although others have been released such as the Nasal PCR Test that was approved by the FDA under the EUA for the collection and testing of nucleic acid from SARS-CoV-2. By increasing lab capacity, Eurofins has prepared for the uptake in testing, as COVID-19 also spike.
Read more here.
More on: News Regulatory
Don’t miss the next article from HealthFirst 100.
Join our mailing list to receive the latest posts from our blog directly in your inbox.